Critical Care: Critical Care: ARDS/ALI |

Electronic Bronchoscopy During Noninvasive Pressure Ventilation via Own Mask Processing in Severe Pneumonia FREE TO VIEW

Yan Peng; Lixin Xie, PhD
Author and Funding Information

Chinese PLA General Hospital, Beijing, China

Copyright 2016, American College of Chest Physicians. All Rights Reserved.

Chest. 2016;149(4_S):A157. doi:10.1016/j.chest.2016.02.163
Text Size: A A A
Published online


SESSION TYPE: Original Investigation Poster

PRESENTED ON: Saturday, April 16, 2016 at 11:45 AM - 12:45 PM

PURPOSE: To evaluate the feasibility and safety of electronic bronchoscopy during noninvasive positive pressure ventilation (NPPV) delivered by own mask processing in immunosuppressed non-HIV/AIDS patients with severe pneumonia, and whether we can get the etiology evidence in time.

METHODS: This is a retrospective matched from respiratory intensive unite (RICU). All of the 22 severe pneumonia patients’ Oxygenation index <150. We give all the group’s NPPV auxiliary electronic bronchoscopy when the patient admitted RICU after the first time. Compare the patients’ vital sign and arterial blood gas (ABG) analysis inspection, inspection before and 2 hours after inspection. To analyze the success rate, the results of pathogenic and 28 days case fatality rate.

RESULTS: Improvement in ABG and vital signs was a little change during inspection before/during/after, except for a greater SiO2, respiratory rate (RR) and oxygenation index (respectively P=0.0001, P=0.001, P=0.0001). During the inspection, the rate of failure is too low (3/21, 14.3%), most of the patients who received the electronic bronchoscopy during NPPV inspection get clearly etiology evidence (16/18, 88.9%). The 28 days mortality was low (3/21, 14.3%).

CONCLUSIONS: In patients with severe pneumonia due to infection who were candidate for endotrcheal intubation because of high BR and low oxygenation index, electronic bronchoscpy during NPPV with early inspection performed by an experienced team to get etiology evidence is a feasible, safe and effective alternative strategy, and reduce the mortality of immunosuppressed ono-HIV/AIDS patients.

CLINICAL IMPLICATIONS: Critically ill patients may be the first time to get their etiological evidence, therefore, based on the symptomatic treatment can reduce antibiotic-associated complications and mortality.

DISCLOSURE: The following authors have nothing to disclose: Yan Peng, Lixin Xie

No Product/Research Disclosure Information




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543